C12Y 304/24075
Lysostaphin
Official title: Lysostaphin (3.4.24.75)
C12Y304/24075 (Lysostaphin) appears on 36 US grants and 57 published applications in this corpus.
Search patents in C12Y- Granted patents
- 36
- Published applications
- 57
- Assignees
- 34
- Inventors
- 107
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 1 | 3 |
| 2014 | 0 | 1 |
| 2015 | 2 | 5 |
| 2016 | 1 | 4 |
| 2017 | 1 | 1 |
| 2018 | 3 | 2 |
| 2019 | 3 | 6 |
| 2020 | 2 | 4 |
| 2021 | 5 | 2 |
| 2022 | 2 | 7 |
| 2023 | 3 | 2 |
| 2024 | 2 | 4 |
| 2025 | 1 | 4 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacteriolysis method, bacteriolysis aid, and method for determining the presence or absence of bacteria4 Aug 2026US 12,699,089 B2Asahi Kasei Kabushiki Kaisha
- Unglycosylated lysostaphin variant protein30 Jun 2026US 12,668,787 B2Trustees of Dartmouth College
- Chimeric proteins for selective lysis of bacteria23 Dec 2025US 12,502,419 B2Bactoclear Holdings PTE. Ltd
- Deimmunized lysostaphin and methods of use1 Oct 2024US 12,104,186 B2Insmed Incorporated
- Unglycosylated lysostaphin variant protein30 Jul 2024US 12,049,653 B2Trustees of Dartmouth College
- Deimmunized lysostaphin and methods of use6 Aug 2026US 2026/0226446 A1Insmed Incorporated
- Bacteriolysis method, bacteriolysis aid, and method for determining the presence or absence of bacteria1 May 2025US 2025/0138008 A1Asahi Kasei Kabushiki Kaisha
- Corynebacterium to treat or limit cutaneous wound infection6 Mar 2025US 2025/0073280 A1Massachusetts Institute of Technology
- Unglycosylated lysostaphin variant protein20 Feb 2025US 2025/0059526 A1Trustees of Dartmouth College
- Rna encoding peptidoglycan hydrolase and use thereof for treating bacterial infection23 Jan 2025US 2025/0027066 A1
Most cited
By later US patents
- Method for treating mastitis and other staphylococcal infections23US 5,760,026 AAMBI Inc. · 1998
- Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains18US 6,569,830 B1AMBI Inc. · 2003
- Composition for treating mastitis and other staphylococcal infections16US 5,858,962 AAMBI Inc. · 1999
- Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains12US 7,122,514 B2Nutrition 21 · 2006
- Method for the treatment of staphylococcal disease11US 6,028,051 AAMBI Inc. · 2000